Stockhead on MSN1d
Neurizon granted US patent for lead drug to treat motor neurone and other neurodegenerative conditionsA patent has been granted in the US covering the use of Neurizon’s lead drug candidate NUZ-001 in neurodegenerative diseases ...
Between now and 2033, the patents on dozens of brand-name medications will expire, allowing generic drugmakers to begin selling cheaper versions. Drug companies stand to lose more than $400 ...
China has applied to patent a drug candidate being developed by Gilead Sciences as the government rushes to find the cure for the deadly coronavirus, a move that could raise questions on ...
AstraZeneca has launched new lawsuits against four generic drug ... patents over Lynparza and that AstraZeneca’s claims are invalid. The drugmakers are requesting a “judicial declaration ...
Can-Fite has already multiple approved patents and corresponding applications in a variety of territories around the world, for different clinical applications of the drug. The anti-obesity patent ...
DUBLIN--(BUSINESS WIRE)--The "AI Driven Drug Discovery Patent Landscape Report 2024" report has been added to ResearchAndMarkets.com's offering. The AI-driven drug discovery report provides a ...
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback